world
health
organis
declar
pandem
caus
newli
discov
due
grow
demand
reagent
use
rna
extract
subsequ
molecular
diagnost
worldwid
risk
kitandor
reagentshortag
extract
detect
sensit
describ
simpl
fast
altern
workflow
molecular
detect
sampl
simpli
heatprocess
minut
prior
rtqpcr
reaction
coronaviru
diseas
caus
novel
sever
acut
respiratori
syndrom
first
notic
wuhan
china
decemb
spread
across
globe
month
largest
manufactur
reagent
molecular
diagnost
like
qiagen
roch
struggl
keep
global
demand
rna
extract
reagent
face
massiv
global
increas
worldwid
shortag
na
extract
kit
result
futur
patient
diagnos
virus
describ
new
simplifi
workflow
molecular
detect
without
na
extract
could
serv
altern
diagnost
laboratori
overcom
chemic
base
kitshortag
na
purif
prior
pcrrtpcr
golden
standard
molecular
diagnost
magna
pure
system
roch
molecular
biochem
indianapoli
ind
wide
use
system
highthroughput
na
purif
mani
public
health
institut
worldwid
howev
roch
announc
emerg
kitshortag
bottleneck
want
investig
realtim
rtpcr
rtqpcr
analysi
could
perform
minim
pretreat
patient
oropharyng
swap
common
sampl
type
collect
patient
suspect
sever
countri
includ
denmark
three
simplifi
approach
without
na
purif
perform
rtqpcr
direct
salinetransport
solut
throatswap
pb
dilut
salinetransport
solut
dilut
phosphatebuff
salin
pb
heatprocess
test
four
differ
heatprocess
aliquot
salinetransport
solut
heatprocess
min
b
min
c
min
min
respect
heatprocess
clinic
sampl
cool
min
use
rtqpcr
reaction
two
rtqpcr
assay
use
publish
wide
use
rtqpcr
assay
egen
combin
sensifast
tm
probe
norox
onestep
realtim
pcr
kit
ii
commerci
rtpcr
kit
altona
diagnost
hamburg
germani
rtqpcr
result
number
posit
ct
valu
differ
approach
compar
rtqpcr
result
magna
pure
purifi
sampl
experi
graviti
limit
suppli
magna
pure
system
highlight
routin
diagnost
laboratori
becam
critic
low
process
cartridg
magna
pure
system
therefor
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
switch
qiacub
connect
system
qiagen
hilden
germani
finish
studi
comparison
simplifi
workflow
na
purif
system
shown
tabl
tabl
figur
respect
analysi
posit
neg
oropharyng
swap
use
sensifast
tm
kit
show
sensit
specif
accuraci
sampl
heatprocess
min
rtqpcr
reaction
compar
magna
pure
purifi
sampl
tabl
fals
posit
detect
observ
two
nonheat
sampl
one
qiacub
purifi
sampl
could
confirm
posit
use
either
magna
pure
purif
simplifi
approach
overal
simplifi
approach
show
lower
sensit
specif
accuraci
compar
qiacub
purifi
sampl
magna
pure
purifi
sampl
analysi
median
ct
valu
interquartil
rang
iqr
detect
nondetect
sampl
shown
tabl
sampl
detect
tendenc
toward
high
ct
valu
pattern
conclus
analysi
clinic
sampl
use
rtpcr
kit
show
signific
inhibit
rtqpcr
reaction
figur
except
magna
pure
qiacub
purifi
sampl
use
newli
emerg
viru
challeng
global
health
system
everi
aspect
includ
abil
provid
suffici
reagent
molecular
diagnost
test
overcom
shorten
suppli
computeris
tomographi
ct
scan
lung
use
diagnosi
mix
result
risk
falseneg
especi
earli
onset
symptom
shortag
diagnost
kit
china
happen
chines
health
institut
diagnos
period
patient
base
clinic
symptom
alon
result
major
peak
report
case
februari
th
clinic
symptom
sometim
nonspecif
cough
mild
fever
sore
throat
fatigu
similar
respiratori
diseas
even
absent
despit
infect
molecular
test
necessari
correct
diagnosi
diagnost
laboratori
purif
oropharyng
swab
patient
usual
perform
use
magna
pure
na
purif
system
diagnosi
subsequ
perform
use
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
sensifast
tm
rtqpcr
assay
studi
show
substitut
magna
pure
purif
step
simpl
heat
min
result
sensit
specif
accuraci
respect
use
sensifast
tm
rtqpcr
assay
supplementari
data
sensifast
tm
rtqpcr
assay
superior
sensit
rtqpcr
kit
complet
inhibit
nonpurifi
sampl
previous
use
qiacub
system
purifi
oropharyng
swab
surpris
qiacub
purif
supposedli
neg
oropharyng
swab
result
weak
posit
signal
ct
use
sensifast
tm
rtqpcr
assay
moreov
posit
result
could
confirm
na
purif
method
specif
rtqpcr
assay
therefor
confirm
patient
sampl
truli
posit
use
qiacub
purif
system
fals
neg
use
magna
pure
system
sensit
specif
accuraci
heat
approach
lower
compar
sampl
confirm
posit
qiacub
due
variat
sensit
specif
accuraci
differ
rtqpcr
assay
recommend
altern
rtqpcr
assay
use
togeth
heatprocess
workflow
valid
implement
clinic
diagnost
heat
oropharyng
swab
min
follow
cool
min
prior
rtqpcr
reaction
sensit
accur
rtqpcr
reaction
perform
purifi
sampl
howev
time
spread
immens
molecular
test
critic
challeng
limit
suppli
reagent
na
purif
may
use
altern
diagnost
method
simpli
heat
sampl
could
serv
easi
fast
inexpens
altern
chemic
extract
kit
would
detect
posit
patient
fals
posit
exempt
review
ethic
committe
system
inform
consent
given
committe
biomed
research
ethic
capit
region
accord
danish
law
assay
develop
project
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
